Longevity & Aging · Metabolic & Cardiometabolic
fasting-mimicking diet causes pancreatic beta-cell regeneration and diabetes reversal
In plain terms: Can the fasting-mimicking diet regrow insulin-producing cells and reverse diabetes in people?
Part of: • Fasting & Time-Restricted Eating
Compelling in mice and human islet cell-culture, but there is NO in-vivo human evidence of FMD-driven beta-cell regeneration or diabetes reversal — the human claim is unproven.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
The evidence (6)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Cheng 2017 · Cell | animal | supports | moderate | MOUSE (T1D/T2D models) plus human islet in-vitro: FMD drove Ngn3-mediated beta-cell regeneration and restored insulin; human data are cell-culture only, no in-vivo human outcome. Longo-lab. |
| Lean 2018 · Lancet | RCT | contradicts | high | Independent human T2D remission RCT (DiRECT, UK): remission achieved via calorie-restriction/weight loss and restored beta-cell FUNCTION (fat clearance), NOT FMD and NOT neogenesis — human remission mechanism differs from the FMD regeneration claim. |
| Spears E et al 2021 · study_type: mechanism | observational | mixed | low | Review of beta-cell regeneration/neogenesis pathways (proliferation vs progenitor differentiation vs transdifferentiation); explicitly notes findings are largely from MOUSE models and that consensus is lacking on relevance to HUMANS. |
| Castelblanco E et al 2025 · study_type: animal | animal | supports | moderate | MOUSE: alternate-day intermittent fasting in KATP-gain-of-function (neonatal diabetes model) mice restored beta-cell autophagic flux and re-established beta-cell identity, lowering blood glucose. No human data. |
| Napoleão A et al 2021 · study_type: mechanism | observational | mixed | low | Review comparing calorie restriction/ketosis-inducing diets including fasting-mimicking diet (FMD) on insulin resistance in HUMANS; concludes benefits on insulin sensitivity/metabolic parameters but reports 'insufficient evidence' for long- |
| Lean 2019 · Lancet Diabetes Endocrinol | RCT | contradicts | high | Independent 2-yr DiRECT data: durable human T2D remission is weight-loss-dependent and reversible on weight regain — no evidence of the FMD-specific beta-cell neogenesis pathway operating in humans. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.